]> Subscribe to the latest newsworthy research about Sleep Disorders as soon as it is published in <em>Neurology</em>^&reg;, the medical journal of the American Academy of Neurology. <em>Neurology</em> is the world's most widely read and highly cited peer-reviewed neurology journal. http://www.aan.com/rss/?event=feed&channel=13 en ababb@aan.com kwiersma@aan.com Thu, 13 Nov 2008 16:30:57 GMT Sat, 21 Nov 2009 09:21:39 GMT AXON RSS Extension http://blogs.law.harvard.edu/tech/rss ababb@aan.com Channel Feedback http://www.aan.com/rss/?event=feed&channel=13 http://www.aan.com/rss/images/channels/channel_13_s.jpg 144 144 Subscribe to the latest newsworthy research about Sleep Disorders as soon as it is published in <em>Neurology</em>^&reg;, the medical journal of the American Academy of Neurology. <em>Neurology</em> is the world's most widely read and highly cited peer-reviewed neurology journal. false 1 http://www.aan.com/rss/index.cfm/getfile/AAN_94.pdf Media Contacts: Angela Babb, ababb@aan.com, (651) 695-2789 Rachel Seroka, rseroka@aan.com, (651) 695-2738 AAN Launches New Book Series to Help Patients and Caregivers ST. PAUL, Minn. - Following up on the success of Neurology Now&reg;, the free and award-winning patient and caregiver magazine of the American Academy of Neurology, the Academy has announced plans to launch a new series of books for neurology patients and caregivers in 2009 to be called Neurology Now Books&trade;. The Academy has expanded its publishing division, AAN Press, to publish this new book series. Titles planned to publish in the Neurology Now Books&trade; series include coping with multiple sclerosis, brain tumors, and taste and smell disorders in the first year. A fourth publication is also planned for late next year. "With one in six people now affected by a neurologic disorder, there's tremendous demand for the latest information on how to best meet the needs of this fast-growing population of patients and caregivers. Neurology Now Books&trade; will fulfill this growing demand," said Lisa M. Shulman, MD, Editor of Neurology Now Books&trade;, and a neurologist with the University of Maryland School of Medicine and Fellow of the American Academy of Neurology. "With the experience the Academy has had in publishing Neurology Now&reg; magazine, it's sought to advance patient care and has developed an appreciation for the needs and concerns of neurology patients and caregivers. Neurology Now Books&trade; will continue to further our mission of improving patient care and public understanding of disorders of the brain and nervous system," said Shulman. Each issue of Neurology Now&reg; magazine reaches nearly one million readers. It is the only consumer magazine in the country devoted to the management of the range of neurologic disorders. The magazine offers information on treatment and cutting-edge research for such neurologic disorders as Alzheimer's disease, epilepsy, migraine, Parkinson's disease and more. For information on receiving a free subscription to Neurology Now&reg; magazine, visit www.neurologynow.com. AAN Press through Demos Medical Publishing published an earlier series of books for neurology patients and caregivers that will continue to be available for purchase via the AAN Store&trade;. Other AAN Press publications are Neurology&reg;, the most widely read and highly cited peer-reviewed neurology journal, Neurology Now&reg; magazine, and Neurology Today&reg;. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, and multiple sclerosis. For more information about the American Academy of Neurology, visit www.aan.com. http://www.aan.com/rss/index.cfm/getfile/AAN_94.pdf ababb@aan.com Tue, 23 Sep 2008 15:04:51 GMT 1 http://www.aan.com/rss/index.cfm/getfile/AAN_1834.pdf People with a sleep disorder that causes them to kick or cry out during their sleep may be at greater risk of developing dementia or Parkinson's disease, according to a study published in the December 24, 2008, online issue of Neurology&reg;, the medical journal of the American Academy of Neurology. The sleep disorder is called REM sleep behavior disorder. People with the disorder do not have the normal lack of muscle tone that occurs during REM sleep, often known as the dream stage of sleep. Instead, they have excessive muscle activity such as punching, kicking, or crying out, essentially acting out their dreams. The study involved 93 people with this type of sleep disorder who had no signs of a neurodegenerative disease, such as dementia or Parkinson's disease. The participants were followed for an average of five years. During that time, 26 of the people developed a neurodegenerative disease. Fourteen developed Parkinson's disease, 11 developed dementia and were diagnosed with either Alzheimer's disease or Lewy body dementia. One person developed multiple system atrophy, a rare disorder that affects movement, blood pressure and other body functions. The estimated five-year risk of developing a neurodegenerative disease was 18 percent, with the 10-year risk at 41 percent and the 12-year risk at 52 percent. "These results are obviously of great interest to people who have this sleep disorder and their physicians and families," said study author Ronald B. Postuma, MD of McGill University in Montreal, Canada, who carried out the studies at the sleep disorders center at the Sacre Coeur hospital, University of Montreal. Postuma is also a member of the American Academy of Neurology. "The results may help us better understand how these neurodegenerative diseases develop. They also suggest that there may be an opportunity for protecting against the progression to disease, perhaps even preventing it before the symptoms can appear." Postuma noted that the study involved only people with no known cause for the REM sleep behavior disorder. The disorder can also be caused by narcolepsy or rare brainstem abnormalities. REM sleep disorder from these causes does not necessarily carry the risk of developing a neurodegenerative disease, he said. The study was supported by grants from the Canadian Institutes of Health Research and the FRSQ (Fonds de la recherché en santé du Quebec) in Montreal, Canada. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Parkinson's disease, ALS (Lou Gehrig's disease), dementia, West Nile virus, and ataxia. For more information about the American Academy of Neurology, visit www.aan.com. http://www.aan.com/rss/index.cfm/getfile/AAN_1834.pdf ababb@aan.com Wed, 24 Dec 2008 22:00:00 GMT 1 http://www.aan.com/rss/index.cfm/getfile/AAN_1879.pdf A new study shows both obesity and a large belly appear to increase the risk of developing restless legs syndrome (RLS), a common sleep disorder characterized by an irresistible urge to move your legs. The research is published in the April 7, 2009, print issue of Neurology&reg;, the medical journal of the American Academy of Neurology. It is estimated that 5-10 percent of adults in the United States have RLS and the disorder often has a substantial impact on sleep, daily activities and quality of life. For the study, researchers questioned 65,554 women and 23,119 men, all of whom were health professionals who took part in the Health Professionals Follow-Up Study or the Nurses' Health Study II. None of the participants had diabetes, arthritis or were pregnant. Of the groups, 6.4 percent of the women and 4.1 percent of the men were identified as having RLS. The research found men and women with a body mass index (BMI) score over 30 were nearly one-and-a-half times more likely to have RLS than people who were not obese. In addition, people who were in the top 20 percent of the group for highest waist circumference were more than one-and-a-half times more likely to have RLS than the bottom 20 percent of the group with the lowest belly size. The results were the same regardless of age, smoking, use of antidepressants or anxiety. "These results may be important since obesity is a modifiable risk factor that is becoming increasingly common in the U.S.," said study author Xiang Gao, MD, PhD, with the Harvard School of Public Health in Boston. "More research is needed to confirm whether obesity causes RLS and whether keeping a low BMI score and small waist size could help prevent RLS." Gao says some studies suggest that obese people have lower dopamine receptor levels in the brain. "Since decreased dopamine function is believed to play a critical role in RLS as well, this could be the link between the two." Dopamine is a chemical naturally produced by the body that transmits signals between nerve cells. The study was supported by a grant from the National Institutes of Health and the National Institute of Neurological Disorders and Stroke. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as multiple sclerosis, restless legs syndrome, Alzheimer's disease, narcolepsy, and stroke. For more information about the American Academy of Neurology, visit www.aan.com. http://www.aan.com/rss/index.cfm/getfile/AAN_1879.pdf ababb@aan.com Mon, 06 Apr 2009 21:00:00 GMT 1 http://www.aan.com/rss/index.cfm/getfile/AAN_1896.pdf A drug widely used to treat seizures and anxiety appears to be an effective treatment for restless legs syndrome (RLS) and helps people with the disorder get a better night's sleep, according to a study that will be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009. RLS affects up to one in ten people. The 12 week study involved 58 people with RLS. Of the group, 30 people received the drug pregabalin and the rest received placebo. Sleep studies were performed at the beginning and end of the research. Researchers found nearly two-thirds of the people who took pregabalin had no RLS symptoms while taking the drug. For people who still had symptoms, those symptoms had improved by 66 percent while taking the drug, compared to the placebo group where symptoms worsened by 29 percent. Sleep also improved for those taking pregabalin. The study showed the group spent more time in slow wave sleep, otherwise known as Stage 3 or deep sleep, and they spent less time in the lighter sleep stages known as Stage 1 or Stage 2 sleep compared to those taking placebo. "Since RLS symptoms get worse at night, it's difficult for people with RLS to get adequate sleep," said study author Diego Garcia-Borreguero, MD, Director of the Sleep Research Institute in Madrid, Spain. "However, our findings show pregabalin helped people get more deep sleep. The drug was well tolerated and is a promising alternative to current treatments because of its superior effects on quality of sleep." Pregabalin has been approved for epilepsy, nerve pain, generalized anxiety and fibromyalgia. RLS is characterized by an urge to move the legs, generally accompanied by unpleasant numbness, tingling, or burning sensations; an increase in symptoms during rest and a partial, temporary relief from symptoms through activity; and a worsening of symptoms in the evening or at night. Symptoms tend to progress with age. The study was supported by Pfizer Inc. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as multiple sclerosis, restless legs syndrome, Alzheimer's disease, narcolepsy, and stroke. For more information about the American Academy of Neurology, visit www.aan.com. http://www.aan.com/rss/index.cfm/getfile/AAN_1896.pdf ababb@aan.com Wed, 29 Apr 2009 19:30:00 GMT